About
We are an awesome team working on improving the health of both patients and nurses.
Micael Törnblom
CEO & Founder
Ida Virtala
Product Manager IV-set
RN MSc Specialist in Oncology
Linda Berndtsson
External Board member &
RA Consultant
Cecilia Löfberg
Chief Financial Officer
Monique Feikes de Groot
Quality Manager
Anna Rydberg
Chief Marketing Officer
Nina Vaher Dahlström
Sales & Logistic Coordinator
Ola Virtala
Assembly Operator & Quality Controller
Mats Dörring
Chairman of the Board
Håkan Svanberg
Board Member
Fredrik Lüning
Board Member
Olle Nilsson
Board Member
Arne Nilsson
Board Member
Open Positions
We see a rapid expansion this year and we are always looking to connect with more enthusiastic people within this field. We are currently seeking people within:
The company
CYTO365 is a Swedish Medtech company founded in 2013 and has since filed over 100 patents.
RondelO™ is leading the way for a fundamental paradigm shift to combat drug incompatibility by its turn valve design. With RondelO™ integrated into an IV-set, it is possible to connect multiple drugs via secondary lines to the RondelO™ inlets and give those drugs one by one without risk of parallel flow and with flushing fluid enabled in between. Our vision is to Aid nurse to do right and combat drug incompatibility by design.
We invest heavily in industrialisation, including multi cavity mould tool and an automation for assembly with capacity of 20 million RondelO™ per year in own clean room GMP-C.
We are co-funded by the European Union.
CYTO365 AB is an ISO 13485 certified company.
Patents
We invests heavily in our patent portfolio and hold multiple approved patents worldwide within infusion technology covering about 50% of worlds population.